Hutchison China Meditech LTD (HCM)

 

Latest News

Change of Directors

RNS Number: 2544U Hutchison China Meditech Limited 16 January 2017 Change of Directors London: Monday , January 16, 2017: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announces with effect from February 1, 2017 , Mr Paul Rutherford Carter has been appointed as Senior Independent Non-Executive Director and member of t...

Change of Directors

RNS Number: 2493U Hutchison China Meditech Limited 16 January 2017 Change of Directors London: Monday , January 16, 2017: Hutchison China MediTech Limited (Chi-Med) (AIM/Nasdaq: HCM) today announces with effect from February 1, 2017 , Mr Paul Rutherford Carter has been appointed as Senior Independent Non-Executive Director and member of the...

Chi-Med launches cancer studies in China

Hutchison China MediTech has initiated a phase II study of sulfatinib in second-line biliary tract cancer patients in China. ...

Fruquintinib Phase I/II Clinical Data at ASCO GI

RNS Number: 2229U Hutchison China Meditech Limited 16 January 2017 Press Release Chi-Med Presents Phase I/II Clinical Data for Selective VEGFR Inhibitor Fruquintinib at the 2017 Gastrointestinal Cancers Symposium London: Monday, January 16 , 2017: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announces that data from the o...

All News

DateHeadlineSource
16-01-17Change of DirectorsRNS
16-01-17Change of DirectorsRNS
16-01-17Chi-Med launches cancer studies in China StockMarketWire
16-01-17Fruquintinib Phase I/II Clinical Data at ASCO GIRNS
16-01-17Sulfatinib Phase II Study in 2nd Line BTC in ChinaRNS
16-01-17Fruquintinib Combination Study in 1st-Line NSCLCRNS
10-01-17 Chi-Med initiates HMPL-523 clinical trialsStockMarketWire
10-01-17Chi-Med Initiates HMPL-523 Clinical TrialsRNS
30-12-16Total Voting RightsRNS
29-12-16Blocklisting Six Monthly ReturnRNS
20-12-16Director's Share DealingRNS
14-12-16Director's Share DealingRNS
06-12-16Chi-Med presents pre-clinical data at ASHStockMarketWire
06-12-16HMPL-523 Pre-clinical Data Presented at ASHRNS
30-11-16Exercise of Share OptionsRNS
30-11-16Total Voting RightsRNS
23-11-16Director Deals - Hutchison China Meditech Ltd (HCM)StockMarketWire
23-11-16Director's Share DealingRNS
23-11-16Chi-Med to Present Data at the 17th WCLCRNS
23-11-16Chi-Med to Present Data at the at the 17th WCLCRNS
14-11-16Chi-Med to present clinical data at ACR/ARHP StockMarketWire
14-11-16Chi-Med Presents Ph I Clinical Data for HMPL-523RNS
01-11-16Director's Share DealingRNS
31-10-16Chi-Med JV gets $59.5m land compensation payment StockMarketWire
31-10-16Joint Venture - US$59.5m Land Compensation PaymentRNS
12-10-16Director Deals - Hutchison China Meditech Ltd (HCM)StockMarketWire
12-10-16Director's Share DealingRNS
16-09-16Broker Forecast - Panmure Gordon issues a broker note on Hutchison China Meditech LtdStockMarketWire
09-08-16Director Deals - Hutchison China Meditech Ltd (HCM)StockMarketWire
09-08-16Director's Share DealingRNS
02-08-16Change of Non-executive DirectorsRNS
02-08-16Chi-Med revenues rise StockMarketWire
02-08-16Chi-Med 2016 Interim ResultsRNS
01-08-16Chi-Med and AZ to accelerate savolitinibStockMarketWire
01-08-16Chi-Med and AstraZeneca to Accelerate SavolitinibRNS
12-07-16The best UK equity funds of 2016Money Observer
05-07-16Chi-Med to Announce 2016 HY Financial ResultsRNS
29-06-16Blocklisting Six Monthly ReturnRNS
27-06-16What are the safest places to store your money post-Brexit?Motley Fool
20-06-16Chi-Med initiation of phase II trial of savolitinib StockMarketWire

RSS feeds

  • Editorial news feed for LSE:HCM Editorial
  • Regulatory news feed for LSE:HCM Regulatory